18 Hrs
Source:
الاقتصادية
Soliman Al-Habib shifts to costly growth
The article discusses the decline in the share price of Dr. Sulaiman Al-Habib Group, despite the company's ongoing profit growth. This is due to the market re-evaluating the risks and costs associated with the large capital expansion they initiated in 2024. The reliance on financing and debt has increased, leading to higher costs and a slowdown in the phased cash flows from new hospitals, resulting in a reassessment of the growth cost rather than a deterioration in operational performance. Although the company continues to generate high revenues and profits, the market remains cautious about rising costs and financing, which has caused the share price to decline despite the company's continued growth.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)